NCT06130631

Brief Summary

Retrospective study of predictors of steroid response in childhood nephrotic syndrom

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

December 3, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 21, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 4, 2023

Last Update Submit

November 10, 2023

Conditions

Nephrotic Syndrome in Children

Outcome Measures

Primary Outcomes (1)

  • Predictors of steroid response in childhood nephrotic syndrom

    Retrospective study of predictors of steroid response in childhood nephrotic syndrom Sach as hypertension, hematuria,raised renal chemistry in pediatric nephrology unit and outpatient outpatient nephrology clinic at assiut university children hospital

    2year

Eligibility Criteria

Age12 Months - 18 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsAll children from 1 year to 18 years
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patient diagnosed with nephrotic syndrom on steroid treatment for 3 years

You may qualify if:

  • all children from 1 year to 18 years treated with steroid for nephrotic syndrom

You may not qualify if:

  • children with other kideny disease Children less than 1 year old Children with secondary nephrotic syndrom

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Anochie I, Eke F, Okpere A. Childhood nephrotic syndrome: change in pattern and response to steroids. J Natl Med Assoc. 2006 Dec;98(12):1977-81.

    PMID: 17225845BACKGROUND

  • Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012 Aug;79(8):1045-55. doi: 10.1007/s12098-012-0776-y. Epub 2012 May 30.

    PMID: 22644544BACKGROUND

Study Officials

  • Maha Radwan Zaki

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maha Radwan Zaki, Doctor

CONTACT

01090963814mahamai071@gmail.com

Asmaa Mahmoud M. Ahmed, Clinical professor

CONTACT

01007041245asmaa_ahmed@aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
71515, Assuit

Study Record Dates

First Submitted

November 4, 2023

First Posted

November 14, 2023

Study Start

December 3, 2023

Primary Completion

December 21, 2024

Study Completion

May 31, 2025

Last Updated

November 14, 2023

Record last verified: 2023-11